1. Home
  2. IPSC vs SELF Comparison

IPSC vs SELF Comparison

Compare IPSC & SELF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • SELF
  • Stock Information
  • Founded
  • IPSC 2019
  • SELF 1983
  • Country
  • IPSC United States
  • SELF United States
  • Employees
  • IPSC 165
  • SELF N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • SELF Real Estate Investment Trusts
  • Sector
  • IPSC Health Care
  • SELF Real Estate
  • Exchange
  • IPSC Nasdaq
  • SELF Nasdaq
  • Market Cap
  • IPSC 49.6M
  • SELF 56.9M
  • IPO Year
  • IPSC 2021
  • SELF N/A
  • Fundamental
  • Price
  • IPSC $0.58
  • SELF $5.53
  • Analyst Decision
  • IPSC Strong Buy
  • SELF
  • Analyst Count
  • IPSC 5
  • SELF 0
  • Target Price
  • IPSC $3.33
  • SELF N/A
  • AVG Volume (30 Days)
  • IPSC 868.9K
  • SELF 24.3K
  • Earning Date
  • IPSC 08-07-2025
  • SELF 08-08-2025
  • Dividend Yield
  • IPSC N/A
  • SELF 5.25%
  • EPS Growth
  • IPSC N/A
  • SELF 15.74
  • EPS
  • IPSC N/A
  • SELF 0.22
  • Revenue
  • IPSC $114,898,000.00
  • SELF $12,622,544.00
  • Revenue This Year
  • IPSC $1,064.82
  • SELF N/A
  • Revenue Next Year
  • IPSC N/A
  • SELF N/A
  • P/E Ratio
  • IPSC N/A
  • SELF $25.33
  • Revenue Growth
  • IPSC 8286.72
  • SELF 3.58
  • 52 Week Low
  • IPSC $0.34
  • SELF $4.60
  • 52 Week High
  • IPSC $3.29
  • SELF $5.89
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 52.16
  • SELF 49.10
  • Support Level
  • IPSC $0.58
  • SELF $5.61
  • Resistance Level
  • IPSC $0.66
  • SELF $5.81
  • Average True Range (ATR)
  • IPSC 0.04
  • SELF 0.13
  • MACD
  • IPSC -0.00
  • SELF -0.04
  • Stochastic Oscillator
  • IPSC 41.52
  • SELF 6.45

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About SELF Global Self Storage Inc.

Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to 13 self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.

Share on Social Networks: